<?xml version="1.0" encoding="UTF-8"?>
<p>Surveillance is critical to inform infectious disease management and control programmes ( 
 <xref rid="ref-41" ref-type="bibr">Klepac 
  <italic>et al.</italic>, 2013
 </xref>; 
 <xref rid="ref-54" ref-type="bibr">Molyneux 
  <italic>et al.</italic>, 2004
 </xref>) and genomic data is emerging as a powerful new surveillance tool ( 
 <xref rid="ref-21" ref-type="bibr">Cotton 
  <italic>et al.</italic>, 2018
 </xref>). Pathogen sequencing has become increasingly routine in well-resourced public health laboratories, but in low- and middle-income countries (LMICs) where most emerging and endemic zoonoses occur, sequencing capacity is more limited and the direct application of genomics-informed surveillance is still at an early stage ( 
 <xref rid="ref-3" ref-type="bibr">Balloux 
  <italic>et al.</italic>, 2018
 </xref>; 
 <xref rid="ref-28" ref-type="bibr">Folarin 
  <italic>et al.</italic>, 2014
 </xref>; 
 <xref rid="ref-29" ref-type="bibr">Gardy &amp; Loman, 2018</xref>).
</p>
